| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/10/2004 | US6689795 Methods for treating dementia due to HIV disease |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics |
| 02/10/2004 | US6689785 Epoxysuccinamide derivatives |
| 02/10/2004 | US6689782 3-piperazinyl-2-diarylurea-quinazolinone derivatives; potentiators of antifungal agents |
| 02/10/2004 | US6689780 Heteroroaromatic amides as inhibitor of factor Xa |
| 02/10/2004 | US6689772 Antineoplastic agents; osteoporosis; polycystic kidney disease; antiviral agents |
| 02/10/2004 | US6689769 Bactericides |
| 02/10/2004 | US6689765 Viricides; antiinflammatory agents |
| 02/10/2004 | CA2297134C A novel process for preparing intermediates or inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 02/10/2004 | CA2291975C Quaternary ammonium compounds |
| 02/05/2004 | WO2004011457A1 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | WO2004011436A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 02/05/2004 | WO2004011427A2 Substituted benzanilides as modulators of the ccr5 receptor |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 02/05/2004 | WO2003074475A3 Substituted aryl ketones |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | WO2002041834A8 Atorvastatin hemi-calcium form vii |
| 02/05/2004 | US20040024216 HMG-CoA reductase inhibitors and method |
| 02/05/2004 | US20040024209 Drugs such as 4-(3-Bromo-4-fluorobenzyl)morpholine used as viricides against herpes viruses |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040024167 Epoxy resins, process for preparation thereof, epoxy resin compositions and cured articles |
| 02/05/2004 | US20040024067 Deacetylase inhibitors |
| 02/05/2004 | US20040024066 E.g., N-(2-(Benzo(b)thiophen-5-ylmethanesulfonyl)-1-(3,4-dichloro- phenyl)- ethyl)-N-hydroxyformamide; gene expression inhibitors of s-CD23; autoimmune disease; antiallergens; matrix metalloprotease enzyme inhibitors |
| 02/05/2004 | US20040024051 C10 heterosubstituted acetate taxanes |
| 02/05/2004 | US20040024040 Inhibitors of GSK-3 and uses thereof |
| 02/05/2004 | US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases |
| 02/05/2004 | US20040024010 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/05/2004 | US20040024000 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023996 Methods and compositions utilizing quinazolinones |
| 02/05/2004 | US20040023993 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba) |
| 02/05/2004 | US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 02/05/2004 | US20040023960 Mammalian metabolites of the compound 2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3- (4-fluoro) phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo) methylmorpholine which is a tachykinin receptor antagonist as antiemetics |
| 02/05/2004 | US20040023958 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 02/05/2004 | US20040023950 N-heterocyclic derivatives as NOS inhibitors |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
| 02/05/2004 | US20040023929 Small molecules for inhibition of function and drug delivery to leukocytes |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040022834 Pharmaceutical oxan preparation |
| 02/05/2004 | DE10234876A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl |
| 02/05/2004 | DE10232094A1 5-Thiaepothilone und 15-disubstituierte Epothilone 5-Thiaepothilone and 15-disubstituted epothilones |
| 02/05/2004 | DE10148618A1 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/05/2004 | CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/04/2004 | EP1386913A1 Pyrrole derivative |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1386166A2 Anti-epileptogenic agents |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385843A1 Arylindenopyridines with pde inhibiting activity |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385834A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
| 02/04/2004 | EP1385831A2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
| 02/04/2004 | EP1385827A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385822A1 Aminopyrrolidine sulfonamides as serine protease inhibitors |
| 02/04/2004 | EP1385820A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 02/04/2004 | EP1385514A1 Spiroindene and spiroindane compounds |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1196640B1 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
| 02/04/2004 | EP1042319B1 Dihydrobenzofurans |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473156A Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 02/04/2004 | CN1473155A Pyrimidine derivatives and herbicides containing the same |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473153A Hetero-anellated ortho-aminophenols |
| 02/04/2004 | CN1473150A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/04/2004 | CN1137118C Water soluble azoles as broad-spectrun antifungals |
| 02/04/2004 | CN1137117C Luminescent aromatic tetrahydric dianhydride containing naphtalene structure and its prepn |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1137096C Method for producing(-1) Cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine |
| 02/03/2004 | US6686473 Process for the production of paroxetine |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |
| 02/03/2004 | US6686369 α-hydrdroxylic acid derivatives, their production and use |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686348 Metalloprotease inhibitors |
| 02/03/2004 | US6686318 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 02/03/2004 | US6685995 Low voltage, wide temperature range driving; high speed response |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 02/03/2004 | CA2067151C Aica riboside analogs |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009573A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009562A1 Substituted triazine kinase inhibitors |
| 01/29/2004 | WO2004009558A2 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 01/29/2004 | WO2004009557A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009551A1 Process for producing 2-substituted pyridine derivative |